DA-3101

N/A

Report date: 2024/05/08 15:10:38

Base Information

Drug NameDA-3101

Drug Alias NameDA-3101

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionFibroblast activation protein alpha antagonistsInterleukin-12 inhibitors

TargetsProlyl endopeptidase FAPInterleukin-12

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesDong-A ST Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesDong-A ST Co Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A